Aveo Pharmaceuticals initiated with a Sell at Stifel Nicolaus
Stifel does not expect Aveo's Tivozanib to gain regulatory approval based on the unexpected overall survival discrepancy in the TIVO-1 trial.
Advertisement
Recommended Stories
‘Americans just work harder’ than Europeans, says CEO of Norway’s $1.6 trillion oil fund, because they have a higher ‘general level of ambition’
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
Fortune•Warren Buffett Says 'When It Rains Gold, Put Out The Bucket' And This High Yield Investment Is Making It Rain
In his 2016 letter to Berkshire Hathaway shareholders, legendary investor Warren Buffett wrote, “Every decade or so, dark clouds will fill the economic skies, and they will briefly rain gold. When downpours of that sort occur, it’s imperative that we ...
Benzinga•Billionaire 'bond king' Bill Gross tells investors to avoid tech and stick to value stocks
Gross said in a post on X to avoid tech, but if you have to invest in the sector, one name stands out.
Business Insider•Microsoft beats Q3 top and bottom lines on cloud strength
Microsoft reported better than anticipated Q3 earnings on Thursday, powered by growth in its cloud products.
Yahoo Finance•Why Are Shares of Intel Stock Crashing After Earnings?
Intel stock dropped 9% after the company reported Q1 earnings. Is it a buy right now?
Motley Fool•1 Unstoppable Stock That Could Join Microsoft, Apple, Nvidia, Alphabet, Amazon, and Meta in the $1 Trillion Club
The combination of artificial intelligence (AI) and cybersecurity is a match made in heaven.
Motley Fool•The US economy may be barrelling towards stagflation, an outcome worse than recession
As US growth shows signs of sputtering and inflation keeps rising, a re-run of the tumultuous 1970s is looking more likely.
Business Insider•Rooting for Trump to fail has made his stock shorters millions
Rooting for Donald Trump to fail has rarely been this profitable. Just ask a hardy band of mostly amateur Wall Street investors who have collectively made tens of millions of dollars over the past month by betting that the stock price of his social media business — Truth Social — will keep dropping despite massive buying by Trump loyalists and wild swings that often mirror the candidate’s latest polls, court trials and outbursts on Trump Social itself.
Associated Press Finance•Hertz loses another $200 million from its EVs
Car-rental operator Hertz reported it lost another $200 million due to its EV gamble.
Yahoo Finance•1 Stock I Wouldn't Touch With a 10-Foot Pole
This company told investors it might go out of business.
Motley Fool•